227 related articles for article (PubMed ID: 32356089)
1. Senotherapeutics and HIV-1 Persistence.
Szaniawski MA; Spivak AM
Curr HIV/AIDS Rep; 2020 Jun; 17(3):219-225. PubMed ID: 32356089
[TBL] [Abstract][Full Text] [Related]
2. Senotherapeutics for HIV and aging.
Szaniawski MA; Spivak AM
Curr Opin HIV AIDS; 2020 Mar; 15(2):83-93. PubMed ID: 31833962
[TBL] [Abstract][Full Text] [Related]
3. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.
Battistini A; Sgarbanti M
Viruses; 2014 Apr; 6(4):1715-58. PubMed ID: 24736215
[TBL] [Abstract][Full Text] [Related]
6. Current views on HIV-1 latency, persistence, and cure.
Melkova Z; Shankaran P; Madlenakova M; Bodor J
Folia Microbiol (Praha); 2017 Jan; 62(1):73-87. PubMed ID: 27709447
[TBL] [Abstract][Full Text] [Related]
7. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
[TBL] [Abstract][Full Text] [Related]
8. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
9. A broad drug arsenal to attack a strenuous latent HIV reservoir.
Stoszko M; Ne E; Abner E; Mahmoudi T
Curr Opin Virol; 2019 Oct; 38():37-53. PubMed ID: 31323521
[TBL] [Abstract][Full Text] [Related]
10. The role of latency reversal agents in the cure of HIV: A review of current data.
Bashiri K; Rezaei N; Nasi M; Cossarizza A
Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
[TBL] [Abstract][Full Text] [Related]
11. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
12. The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL; Marsili G; Battistini A; Sgarbanti M
Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
[TBL] [Abstract][Full Text] [Related]
13. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.
Sluis-Cremer N
Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046
[TBL] [Abstract][Full Text] [Related]
15. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
Kim EC; Kim JR
BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
[TBL] [Abstract][Full Text] [Related]
16. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
17. Latency reversal and viral clearance to cure HIV-1.
Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
[TBL] [Abstract][Full Text] [Related]
18. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
Macedo AB; Novis CL; De Assis CM; Sorensen ES; Moszczynski P; Huang SH; Ren Y; Spivak AM; Jones RB; Planelles V; Bosque A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282829
[TBL] [Abstract][Full Text] [Related]
19. Cellular Determinants of HIV Persistence on Antiretroviral Therapy.
Mikhailova A; Valle-Casuso JC; Sáez-Cirión A
Adv Exp Med Biol; 2018; 1075():213-239. PubMed ID: 30030795
[TBL] [Abstract][Full Text] [Related]
20. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
